2-Cyclopropyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-8-carboxylic acid hydrochloride

Catalog No. :
ACTPKA732
CAS No. :
2757731-58-9
Molecular Formula :
C11H15ClN2O2
Molecular Weight :
242.71

IUPAC Name:2-cyclopropyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-8-carboxylic acid hydrochloride

2-Cyclopropyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-8-carboxylic acid hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$79.00Login to see priceInquiryInquiry
250mg95%$133.00Login to see priceInquiryInquiry
1g95%$348.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Cyclopropyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-8-carboxylic acid hydrochloride
IUPAC Name2-cyclopropyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-8-carboxylic acid hydrochloride
Molecular FormulaC11H15ClN2O2
Molecular Weight242.71
SMILESCl.O=C(O)C1CCCN2C=C(C3CC3)N=C12
InChI KeyGZYJJUWJCIHIDI-UHFFFAOYSA-N
Synonym2-Cyclopropyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-8-carboxylic acid hydrochloride;Imidazo[1,2-a]pyridine-8-carboxylic acid, 2-cyclopropyl-5,6,7,8-tetrahydro-, hydrochloride (1:1)
CAS No.2757731-58-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTPKA732 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTPKA732 route product structure diagram
    ACTPKA7322757731-58-9
Inquiry

2. ACTPKA732 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTPKA732 route product structure diagram
    ACTPKA7322757731-58-9
Inquiry

Comments (0)